Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium

Poitiers University Hospital

Status: Completed

Conditions: Prostate Cancer

Treatments: Diagnostic Test: fluorocholine PET/CT

Study type: Interventional

Funder types: Other

Identifiers

NCT03105869

RECHOL

Details and patient eligibility

About

Monocentric study. Objective : Determination of the repeatability of fluorocholine PET/CT in prostate cancer

Full description

A second PET/CT with fluorocholine is performed within 2 weeks after a first examination performed in patient referred for an initial prostate cancer or a biological suspicion of relapse.

Enrollment: 20 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria :

• biological suspicion of relapse of prostate cancer or initial staging of prostate cancer
• positive PET/CT with fluororocholine

Exclusion criteria :

-none

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

fluorocholine PET/CT

Experimental group

Description:

all patients will undergo a second PET/CT with fluorocholine

Treatment:

Diagnostic Test: fluorocholine PET/CT